Note: Ingredients listed on restricted chemical lists
EC/CAS
204-661-8/123-91-1
Name of the chemical
1,4-Dioxane
Concentration
<=100
EC/CAS
204-881-4/128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
<0.0025
General Information
Revision date
2024-11-11
Product name
1, 4 -DIOXAN
CAS No.
123-91-1
1.2.1 Relevant identified uses
Chemical for analysis and production
Manufacturer Name
RCI LABSCAN LIMITED
Icons in SDS
Company Information
company name
RCI LABSCAN LIMITED
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H335, H350
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H225 Highly flammable liquid and vapour. H319 Causes serious eye irritation. H335 May cause respiratory irritation. H350 May cause cancer. EUH019 May form explosive peroxides. EUH066 Repeated exposure may cause skin dryness or cracking.
Precautionary statements
P203 Obtain, read and follow all safety instructions before use. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 Wear protective gloves/protective clothing/eye protection/face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water [or shower]. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P318 IF exposed or concerned: Get medical advice.
2.3 Other hazards
None
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Flammable liquids (Category 2), H225 Eye irritation (Category 2), H319 Carcinogenicity (Category 1B), H350 Specific target organ toxicity - single exposure (Category 3), H335 For the full text of the H-Statements mentioned in this Section, see Section 16.
